Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis

by Sahityasri Thapi, Amanda Leiter, Matthew Galsky, Emily J. Gallagher
Published 2019-09-01

Evolving Patterns of Metastasis in Renal Cell Carcinoma

by Justin Lin, Yue Zhang, Wei Hou, Qian Qin, Matthew Galsky, William Oh, Che-Kai Tsao
Published 2021-10-01

569 Dissecting resistance to immune checkpoint blockade in bladder cancer: single cell analyses link pro-inflammatory macrophages and IL-6 to CD8+ T cell suppression

by Nina Bhardwaj, Seunghee Kim-Schulze, Matthew Galsky, John Sfakianos, Amir Horowitz, Kristin Beaumont, Michelle A Tran, Adam M Farkas, Dina Youssef
Published 2023-11-01

82 Single-cell RNA sequencing and CITE-Seq analysis of bladder cancer patient urine with matched tumor and peripheral blood suggests urine as a window into the tumor immune microen...

by Nina Bhardwaj, Timothy O’Donnell, Matthew Galsky, John Sfakianos, Amir Horowitz, Adam Farkas, Kristin Beaumont, Reza Mehrazin, Peter Wiklund, Michelle Tran
Published 2021-11-01

1465 Multiplex imaging identifies unique immunophenotypic and spatial characteristics associated with response to immune checkpoint inhibitors (ICIs) in metastatic urothelial cance...

by Padmanee Sharma, Seunghee Kim-Schulze, Justin David, John-William Sidhom, Sacha Gnjatic, Guray Akturk, Matthew Galsky, Saurabh Gupta, Jonathan Anker, Sudeh Izadmehr
Published 2023-11-01

1309 Deep learning reveals predictive immune signature of response to checkpoint blockade in multiplexed spatial immunohistochemistry data

by Padmanee Sharma, Seunghee Kim-Schulze, Justin David, John-William Sidhom, Sacha Gnjatic, Guray Akturk, Matthew Galsky, Saurabh Gupta, Jonathan Anker, Sudeh Izadmehr
Published 2023-11-01

Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors

by Fotis Nikolos, Kazukuni Hayashi, Xen Ping Hoi, Mark Ellie Alonzo, Qianxing Mo, Armine Kasabyan, Hideki Furuya, Jane Trepel, Dolores Di Vizio, Jlenia Guarnerio, Dan Theodorescu, Charles Rosser, Andrea Apolo, Matthew Galsky, Keith Syson Chan
Published 2022-03-01

Protein Profiling of Bladder Urothelial Cell Carcinoma.

by Jinghai Hu, Fei Ye, Miao Cui, Peng Lee, Chengguo Wei, Yuanyuan Hao, Xiaoqing Wang, Yanbo Wang, Zhihua Lu, Matthew Galsky, Russell McBride, Li Wang, Dongwen Wang, Carlos Cordon-Cardo, Chunxi Wang, David Y Zhang
Published 2016-01-01

Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis

by Qian Qin, Tomi Jun, Bo Wang, Vaibhav G. Patel, George Mellgard, Xiaobo Zhong, Mahalya Gogerly-Moragoda, Anish B. Parikh, Amanda Leiter, Emily J. Gallagher, Parissa Alerasool, Philip Garcia, Himanshu Joshi, MBBS, Matthew Galsky, William K. Oh, Che-Kai Tsao
Published 2022-08-01

266 Tumour mutation burden (TMB) and efficacy outcomes in the phase III DANUBE study of advanced urothelial carcinoma (UC)

by Weimin Li, Ross Stewart, Thomas Powles, Joaquim Bellmunt, Feng Xiao, Ashok Gupta, Jill Walker, Melissa de los Reyes, Matthew Galsky, Sophie Wildsmith, Anne L’Hernault, Hannah Bye, Philip He, Qu Zhang, Rajiv Raja, Wendy Levin, Alexandra Drakaki, Michiel van der Heijden
Published 2020-11-01

Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases.

by Charles C L Tong, Eric C Ko, Max W Sung, Jamie A Cesaretti, Richard G Stock, Stuart H Packer, Kevin Forsythe, Eric M Genden, Myron Schwartz, K H Vincent Lau, Matthew Galsky, Junko Ozao-Choy, Shu-Hsia Chen, Johnny Kao
Published 2012-01-01

289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting

by Nina Bhardwaj, Marshall Posner, Philip Friedlander, John Mandeli, Sacha Gnjatic, Eric Schadt, Samir Parekh, Julia Kodysh, Alex Rubinsteyn, John Finnigan, Ana Blazquez, Mansi Saxena, Marcia Meseck, Daniela Delbeau, Matthew Galsky, Deborah Doroshow, Brett Miles, Krysztof Misiukiewicz, Hanna Irie, Amy Tiersten, Andrea Wolf, Jeffrey Hammerbacher, Michael Donovan, Rachel Brody
Published 2020-11-01

314 NKG2A and HLA-E define a novel alternative immune checkpoint axis in bladder cancer

by Li Wang, Jun Zhu, Pedro Romero, Nina Bhardwaj, Matthew Galsky, Rachel Brody, John Sfakianos, Amir Horowitz, Karl-Johan Malmberg, Brian Lee, Robert Sebra, Berengere Salome, Andrew Charap, Adam Farkas, Daniel Geanon, Geoffrey Kelly, Ronaldo de Real, Kristin Beaumont, Sanjana Shroff, Ying-Chih Wang, Yuan-Shuo Wang, Alice Kamphorst, Emanuela Marcenaro, Yuko Yuki, Maureen Martin, Mary Carrington, Reza Mehrazin, Peter Wiklund
Published 2021-11-01

621 NKG2A and HLA-E define a novel mechanism of resistance to immunotherapy with M. bovis BCG in non-muscle-invasive bladder cancer patients

by Li Wang, Jun Zhu, Nina Bhardwaj, Seunghee Kim-Schulze, Jingjing Qi, Manishkumar Patel, Matthew Galsky, Rachel Brody, John Sfakianos, Amir Horowitz, Brian Lee, Robert Sebra, Berengere Salome, Adam Farkas, Daniel Geanon, Geoffrey Kelly, Ronaldo de Real, Kristin Beaumont, Sanjana Shroff, Ying-Chih Wang, Reza Mehrazin, Peter Wiklund, Jorge Daza, Y Alice Wang, Daniel Ranti, Elliot Merritt, Julie-Ann Cavallo-Fleming, Everado Hegewisch-Solloa, Emily Mace, Michelle Tran, Tin Htwe Thin, Monica Garcia-Barros, Dominic LaRoche, Yong Lee, Anna Tocheva, Benjamin Hopkins
Published 2021-11-01